Trial ID or NCT#

NCT02289560

Status

NOT RECRUITING

Purpose

The objective of this prospective, multi site, single-arm study is to capture the efficacy of treatment using the ExAblate Transcranial System and to further demonstrate safety in medication-refractory tremor in patients with essential tremor (ET).

Official Title

A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects

Eligibility Criteria

Ages Eligible for Study: Older than 22 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Pejman Ghanouni, MD, PhD
Radiologist
Assistant Professor of Radiology (General Radiology) and, by courtesy, of Neurosurgery and of Urology at the Stanford University Medical Center
Veronica E. Santini, MD
Movement disorders specialist
Clinical Associate Professor, Neurology & Neurological Sciences

Contact us to find out if this trial is right for you.

CONTACT

Evalina Salas
(650) 724-4131